FDA Approved Medical Products for:

Congenital sucrase-isomaltase deficiency

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Sacrosidase
Trade Name
(Manufacturer Name)
(QOL Medical, LLC)
The FDA has approved this product to be used in this manner.
Oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrease-isomaltase deficiency.
More Information about this product Drug Information Portal